| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $90.9M | +68.2% |
| SG&A Expense | $23.5M | +33.1% |
| Operating Income | -$114.4M | -59.6% |
| Income Tax | $0 | — |
| Net Income | -$100.2M | -48.1% |
| EPS (Basic) | -$1.57 | -24.6% |
| EPS (Diluted) | -$1.57 | -24.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.1M | +291.5% |
| Current Assets | $327.0M | -8.4% |
| Total Assets | $340.0M | -7.4% |
| Current Liabilities | $16.8M | +1.1% |
| Total Liabilities | $21.2M | +4.0% |
| Stockholders' Equity | $318.8M | -8.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$91.9M | -74.7% |
| Capital Expenditures | $5.7M | +3.6% |
| Investing Cash Flow | $102.9M | +245.8% |
| Financing Cash Flow | $53.2M | -59.0% |
| Free Cash Flow | -$97.7M | -67.9% |